← Open Payments lookup

RENEE FRIESNER: Open Payments

NPI 1396343422 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,156 in 56 payments from 15 companies in 2025. Trend: 2023 $536 · 2024 $1,432 · 2025 $1,156

Food & beverage: $1,156
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$335
Neurocrine BioSciences, Inc.8$189
Otsuka America Pharmaceutical, Inc.5$111
Vanda Pharmaceuticals Inc.5$107
ABBVIE INC.5$94
Janssen Pharmaceuticals, Inc3$68
Axsome Therapeutics, Inc.2$49
Teva Pharmaceuticals USA, Inc.2$37
Supernus Pharmaceuticals, Inc.2$37
Alkermes, Inc.1$25

Products named: CAPLYTA, INGREZZA, HETLIOZ, VRAYLAR, REXULTI, INVEGA SUSTENNA, ABILIFY ASIMTUFII, Auvelity.

Industry payments across CA — which companies pay providers there.